<div>Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18&ndash;59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.</div>